Sale to Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
Zymergen Inc. (NASDAQ: ZY) and ("the company") is a biotech company that designs and produces bio-advantaged molecules, microbes and materials for diverse end markets. The company leverages its proprietary synthetic biofacturing platform with a best-in-class metagenomics database and a modular laboratory automation offering enabling production of highly differentiated products at scale and reduced cost.